Asthma and Allergy Center of Chicago, SC

River Forest, Illinois 60305

1 studies enrolling now · 11 studies all time

What they study most

Allergy, Peanut, Asthma, COPD, Chronic Inducible Urticaria, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Chronic Spontaneous Urticaria, Chronic Spontaneous Urticaria (CSU)

Studies at this site

• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts — Completed
• A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines — Running, not enrolling
• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines — Completed
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients — Completed
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) — Completed
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• Study of Daclizumab in Patients With Chronic, Persistent Asthma — Completed
• Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO) — Stopped early